Purpose

This study will evaluate a new form of non-invasive deep brain therapy for individuals with post-traumatic stress disorder (PTSD). Low-intensity transcranial focused ultrasound stimulation will first be delivered using a range of stimulation parameters during psychophysical and physiological monitoring. A well-tolerated stimulation protocol will be selected for subsequent testing in a blinded randomized sham-controlled cross-over trial. The trial will evaluate brain target engagement using magnetic resonance imaging and numerical scales of PTSD, cognitive performance, and mood.

Condition

Eligibility

Eligible Ages
Between 18 Years and 65 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Positive PTSD diagnosis; PCL-5 > 20

Exclusion Criteria

  • Inability to complete MRI - Suicidal ideation

Study Design

Phase
Phase 1/Phase 2
Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover Assignment
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Active stimulation
Low-intensity transcranial focused ultrasound stimulation of deep brain targets affected by PTSD.
  • Device: Diadem
    The device delivers low-intensity ultrasonic waves into specified brain targets.
Sham Comparator
Sham stimulation
Sham stimulation that applies the device in the same way as verum but only delivers auditory sounds correspoding to the ultrasonic pulses.
  • Device: Diadem
    The device delivers low-intensity ultrasonic waves into specified brain targets.

Recruiting Locations

More Details

Status
Recruiting
Sponsor
University of Utah

Study Contact

Jan Kubanek, PhD
801-213-1418
jan.kubanek@utah.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.